References

1. Wysowski DK, et al. Use of medications for erectile dysfunction in the United States, 1996 through 2001. J Urol 2003 Mar;169(3):1040-2.

2. Bairey Merz CN, et al. Cholesterol-lowering medication, cholesterol level, and reproductive hormones in women: the Women’s Ischemia Syndrome Evaluation (WISE). Am J Med 2002 Dec 15;113(9):723-7.

3. Pugh PJ, et al. Testosterone: a natural tonic for the failing heart. QJ Med 2000; 93:689-694.

4. Gray A, et al. Age, disease, and changing sex hormone levels in middle-aged men: results of the Massachusetts Male Aging Study. J Clin Endocrinol Metab 1991 Nov;73(5):1016-25.

5. de Lignieres B. Andropause and its management in the aged male. Presse Med 2002 Nov 23;31(37 Pt 1):1750-9.

6. Channer KS, et al. Cardiovascular effects of testosterone: implications of the “male menopause”? Heart 2003 Feb;89(2):121-2.

7. Gruenewald DA, et al. Testosterone Supplementation Therapy for Older Men: Potential Benefits and Risks. J Am Geriatr Soc 2003 Jan;51(1):101-115.

8. de Kruif P. The Male Hormone. New York:Harcourt, Brace and Company; 1945.

9. Malgor LA, et al. Blockade of the in vitro effects of testosterone and erythropoietin on Cfu-E and Bfu-E proliferation by pretreatment of the donor rats with cyproterone and flutamide. Acta Physiol Pharmacol Ther Latinoam 1998;48(2):99-105

10. Szulc P, et al. Osteoporosis in the aged male. Presse Med 2002 Nov 23;31(37 Pt 1):1760-9.

11. Gruenewald DA, et al. Testosterone Supplementation Therapy for Older Men: Potential Benefits and Risks. J Am Geriatr Soc 2003 Jan;51(1):101-115.

12. Ettinger SM. Myocardial infarction and unstable angina: gender differences in therapy and outcomes. Curr Womens Health Rep 2003 Apr;3(2):140-8.

13. Friedl KE, et al. High-density lipoprotein cholesterol is not decreased if an aromatizable androgen is administered. Metabolism 1990 Jan;39(1):69-74.

14. Heald AH, et al. Significant ethnic variation in total and free testosterone concentration. Clin Endocrinol (Oxf) 2003 Mar;58(3):262-6.

15. Rioufol G, et al. Arch Mal Coeur Vaiss 2002 Dec;95(12):1210-4.

16. Wright, J, et al. Maximize you Vitality & Potency. California: Smart Publications. 1999. 120

17. Wright, J, et al. Maximize you Vitality & Potency. California: Smart Publications. 1999. 120

18. Brevetti G, et al. Intermittent claudication: pharmacoeconomic and quality-of-life aspects of treatment. Pharmacoeconomics 2002;20(3):169-81.

19. Jaegere Pd P, et al. Long-term clinical outcome after stent implantation in coronary arteries. Int J Cardiovasc Intervent 1999;2(1):27-34.

20. Honderick T, et al. A prospective, randomized, controlled trial of benzodiazepines and nitroglycerine or nitroglycerine alone in the treatment of cocaine-associated acute coronary syndromes. Am J Emerg Med 2003 Jan;21(1):39-42.

21. Moller J, et al. Testosterone treatment of cardiovascular diseases. Berlin:Springer-Verlag; 1984.

22. Lesser M. Testosterone propionate therapy in one hundred cases of angina pectoris. J Clin Endocrinol. 1946;6:549-557.

23. Izumi S, et al. Improvement of peripheral neuropathy by testosterone in a patient with 48,XXYY syndrome. Tokai J Exp Clin Med 2000 Jun;25(2):39-44.

24. Phillips GB, et al. The association of hypotestosteronemia with coronary artery disease in men. Arterioscler Thromb. 1994;14:701-6.

25. Hak AE, et al. Low levels of endogenous androgens increase the risk of atherosclerosis in elderly men: the Rotterdam study. J Clin Endocrinol Metab 2002 Aug;87(8):3632-9.

26. Tsujimura A, et al. The clinical studies of sildenafil for the ageing male. Int J Androl 2002 Feb;25(1):28-33.

27. Gruenewald DA, et al. Testosterone Supplementation Therapy for Older Men: Potential Benefits and Risks. J Am Geriatr Soc 2003 Jan;51(1):101-115.

28. Kontoleon PE, et al. Hormonal profile in patients with congestive heart failure. Int J Cardiol 2003 Feb;87(2-3):179-83.

29. Knowlton AA, et al. Heat-shock factor-1, steroid hormones, and regulation of heat-shock protein expression in the heart. Am J Physiol Heart Circ Physiol 2001 Jan;280(1):H455-64.

30. Kaczmarek A, et al. The association of lower testosterone level with coronary artery disease in postmenopausal women. Int J Cardiol 2003 Jan;87(1):53-7.

31. Allolio B, et al. Osteoporosis in the male. Med Klin 2000 Jun 15;95(6):327-38.

32. Szulc P, et al. Osteoporosis in the aged male. Presse Med 2002 Nov 23;31(37 Pt 1):1760-9.

33. Weinreb M, et al. Histomorphometrical analysis of the effects of the bisphosphonate alendronate on bone loss caused by experimental periodontitis in monkeys. J Periodontal Res 1994 Jan;29(1):35-40.

34. Pope HG, et al. Testosterone gel supplementation for men with refractory depression: a randomized, placebo-controlled trial. Am J Psychiatry 2003 Jan;160(1):105-11.

35. Testosterone and depression in men. Treatment update 2000 May;12(3):7-8.

36. Perry PJ, et al. Testosterone therapy in late-life major depression in males. J Clin Psychiatry 2002 Dec;63(12):1096-101.

37. Cohen PG. Aromatase, adiposity, aging and disease. The hypogonadal-metabolic-atherogenic-disease and aging connection. Med Hypotheses 2001 Jun;56(6):702-8

38. Zumoff B. Hormonal abnormalities in obesity. Acta Med Scand Suppl 1988;723:153-60.

39. Vermeulen A, et al. Estradiol in elderly men. Aging Male 2002 Jun;5(2):98-102.

40. Novak A, et al. Andropause and quality of life: findings from patient focus groups and clinical experts. Maturitas 2002 Dec 10;43(4):231-7.

41. Padula GD et al. Normalization of serum testosterone levels in patients treated with neoadjuvant hormonal therapy and three-dimensional conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2002 Feb 1;52(2):439-43.

42. Wu CY, et al. Age related testosterone level changes and male andropause syndrome. Changgeng Yi Xue Za Zhi 2000 Jun;23(6):348-53.

43. Vermeulen A, et al. Neuroendocrinological aspects of aging. Verh K Acad Geneeskd Belg 1994;56(4):267-80.

44. Amory JK, et al. Endocrine regulation of testicular function in men: implications for contraceptive development. Mol Cell Endocrinol 2001 Sep;182(2):175-9.

45. Vermeulen A, et al. Estradiol in elderly men. Aging Male 2002 Jun;5(2):98-102.

46. Rudzinski W, et al. Effects of estrogens on the brain and implications for neuro-protection. Neurol Neurochir Pol 2002 Jan-Feb;36(1):143-56.

47. McConnell JD, et al. Androgen ablation and blockade in the treatment of benign prostatic hyperplasia. Urol Clin North Am 1990 Aug;17(3):661-70.

48. Crook JM, et al. Intermittent androgen suppression in the management of prostate cancer. Urology 1999 Mar;53(3):530-4.

49. Kellis JT, et al. Inhibition of human estrogen synthetase (aromatase) by flavones. Science 1984 Sep 7;225(4666):1032-4.

50. Dhawan K, et al. Beneficial effects of chrysin and benzoflavone on virility in 2-year-old male rats. J Med Food 2002 Spring;5(1):43-8.

51. Legssyer A, et al. Cardiovascular effects of Urtica dioica L. in isolated rat heart and aorta. Phytother Res 2002 Sep;16(6):503-7.

52. Schottner M, et al. Lignans from the roots of Urtica dioica and their metabolites bind to human sex hormone binding globulin (SHBG). Planta Med 1997 Dec;63(6):529-32.

53. Waynberg J, et al. Effects of Herbal vX on libido and sexual activity in premenopausal and postmenopausal women. Adv Ther 2000 Sep-Oct;17(5):255-62.

54. Wright, J, et al. Maximize you Vitality & Potency. California: Smart Publications. 1999;113.

55. Waynberg J. Aphrodisiacs: Contributions to the clinical evaluation of the taditional use of Ptychopetalum. The First International Congress on Ethnopharmacology, France, June, 1990.